Please provide your email address to receive an email when new articles are posted on . Stereotactic radiosurgery conferred equivalent OS as whole-brain radiation but with less cognitive decline in ...

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest ...

Stereotactic radiosurgery (SRS) represents a paradigm shift in the management of brain metastases, offering a non‐invasive technique that delivers highly focused radiation to targeted lesions with ...

Stereotactic radiotherapy gives radiotherapy from many different angles around the body. The beams meet at the tumour. This means that the tumour receives a high dose of radiation and the tissues ...

Stereotactic radiosurgery is performed using Cyberknife, a robotic radiosurgery system which delivers targeted doses of radiation with sub-millimeter accuracy while minimizing damage to surrounding ...

Of the study participants, 182 received stereotactic radiosurgery, while 79 did not. The patients who underwent radiosurgery using the Gamma Knife system showed consistently better tumor control over ...

Trans-sphenoidal neurosurgery is the gold standard treatment for pituitary adenomas, but it can be contraindicated or ineffective. Stereotactic radiosurgery is a procedure aimed at controlling hormone ...

November 6, 2009 — Results from a long-term cohort study in patients with medically refractory Parkinson's disease (PD) and essential tremor (ET) suggest that stereotactic radiosurgery (SRS) provides ...

Stereotactic radiosurgery appears to be feasible, safe, and effective for patients with 15 or more brain metastases and may be a viable alternative to whole brain radiation therapy (WBRT) alone in ...

The one-year Radiosurgery Fellowship at the University of Alabama at Birmingham offers comprehensive subspecialty training in stereotactic radiosurgery. The program provides fellows exposure to a ...

American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment ...

Brain metastases are the most common intracranial malignancy. Incidence of brain metastases has risen as systemic therapies have improved and patients with metastatic disease live longer. Whole-brain ...